Survivin: A novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 16-24

  Si, Rui ^a   Tao, Ling ^a   Zhang, Hai F ^b   Yu, Qiu J ^a   Zhang, Rui ^b   Lv, An L ^a   Zhou, Ning ^a   Cao, Feng ^a   Guo, Wen Y ^a   Ren, Jun ^c   Wang, Hai C ^a   Gao, Feng ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Insulin; Ischemia reperfusion; MTOR; Survivin

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; SURVIVIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; ISOLATED HEART; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; IN SITU NICK-END LABELING; INSULIN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

ADENOVIRIDAE; RATTUS; SAL VIEJA VIRUS;

EID: 78650826494     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.017     Document Type: Article

References (47)

1. Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword?. J Clin Invest 1985, 76:1713-1719.
2. Ambrosio G., Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999, 138:S69-S75.
3. Yellon D.M., Baxter G.F. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?. Heart 2000, 83:381-387.
4. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502.
5. Freude B., Masters T.N., Robicsek F., Fokin A., Kostin S., Zimmermann R., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 2000, 32:197-208.
6. Aikawa R., Nawano M., Gu Y., Katagiri H., Asano T., Zhu W., et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000, 102:2873-2879.
7. Ma H., Zhang H.F., Yu L., Zhang Q.J., Li J., Huo J.H., et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res 2006, 69:57-65.
8. Jonassen A.K., Sack M.N., Mjos O.D., Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001, 89:1191-1198.
9. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004, 61:448-460.
10. Conte M.S., Altieri D.C. Survivin regulation of vascular injury. Trends Cardiovasc Med 2006, 16:114-117.
11. Kaga S., Zhan L., Altaf E., Maulik N. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 2006, 40:138-147.
12. Yao L.L., Wang Y.G., Cai W.J., Yao T., Zhu Y.C. Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 2007, 120:895-907.
13. Fukuda S., Kaga S., Sasaki H., Zhan L., Zhu L., Otani H., et al. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol 2004, 36:547-559.
14. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999, 99:1685-1691.
15. Fuglesteg B.N., Suleman N., Tiron C., Kanhema T., Lacerda L., Andreasen T.V., et al. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol 2008, 103:444-453.
16. Gao F., Yue T.L., Shi D.W., Christopher T.A., Lopez B.L., Ohlstein E.H., et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 2002, 53:414-422.
17. Liu H.R., Tao L., Gao E., Lopez B.L., Christopher T.A., Willette R.N., et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res 2004, 62:135-144.
18. Li J., Zhang H., Wu F., Nan Y., Ma H., Guo W., et al. Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 2008, 36:1551-1558.
19. Esumi K., Nishida M., Shaw D., Smith T.W., Marsh J.D. NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol 1991, 260:H1743-H1752.
20. Su H., Sun X., Ma H., Zhang H.F., Yu Q.J., Huang C., et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 2007, 293:E629-E635.
21. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3:917-921.
22. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008, 8:61-70.
23. Guha M., Altieri D.C. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009, 8:2708-2710.
24. Bafford R., Sui X.X., Wang G., Conte M. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: potential relevance to vein graft hyperplasia. Surgery 2006, 140:289-296.
25. Blanc-Brude O.P., Teissier E., Castier Y., Leseche G., Bijnens A.P., Daemen M., et al. IAP survivin regulates atherosclerotic macrophage survival. Arterioscler Thromb Vasc Biol 2007, 27:901-907.
26. Moran E.P., Agrawal D.K. Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis. Exp Mol Pathol 2007, 83:11-16.
27. Abbate A., Scarpa S., Santini D., Palleiro J., Vasaturo F., Miller J., et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006, 111:371-376.
28. Levkau B., Schafers M., Wohlschlaeger J., von Wnuck Lipinski K., Keul P., Hermann S., et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 2008, 117:1583-1593.
29. Stenslokken K.O., Rutkovskiy A., Kaljusto M.L., Hafstad A.D., Larsen T.S., Vaage J. Inadvertent phosphorylation of survival kinases in isolated perfused hearts: a word of caution. Basic Res Cardiol 2009, 104:412-423.
30. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
31. Heusch G. No risk, no ... cardioprotection? A critical perspective. Cardiovasc Res 2009, 84:173-175.
32. Heusch G. Postconditioning: old wine in a new bottle?. J Am Coll Cardiol 2004, 44:1111-1112.
33. Siddall H.K., Warrell C.E., Yellon D.M., Mocanu M.M. Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 2008, 103:560-568.
34. Fan W.J., van Vuuren D., Genade S., Lochner A. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol 2010, 105:495-511.
35. Burley D.S., Ferdinandy P., Baxter G.F. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 2007, 152:855-869.
36. Costa A.D., Pierre S.V., Cohen M.V., Downey J.M., Garlid K.D. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 2008, 77:344-352.
37. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?. J Mol Cell Cardiol 2009, 47:32-40.
38. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 2008, 120:172-185.
39. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009, 104:15-18.
40. Schwartz L.M., Lagranha C.J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 2006, 290:H1011-H1018.
41. Bhamra G.S., Hausenloy D.J., Davidson S.M., Carr R.D., Paiva M., Wynne A.M., et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 2008, 103:274-284.
42. Hausenloy D.J., Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006, 70:240-253.
43. Li J., Wu F., Zhang H., Fu F., Ji L., Dong L., et al. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009, 47:512-519.
44. Lawlor M.A., Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci 2001, 114:2903-2910.
45. Proud C.G. Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 2007, 403:217-234.
46. Moschella P.C., Rao V.U., McDermott P.J., Kuppuswamy D. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells. J Mol Cell Cardiol 2007, 43:754-766.
47. Huang S., Houghton P.J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 2002, 3:295-304.